Welcome to our dedicated page for Research Solutions SEC filings (Ticker: RSSS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trying to decode how much Research Solutions earns from Article Galaxy subscriptions versus one-off article transactions? Or maybe you鈥檇 like an alert the moment a Form 4 shows a director buying stock after a new AI add-on launch. Investors come to this page because RSSS filings mix SaaS metrics, content-licensing costs, and acquisition accounting鈥攐ften in well over 100 pages of disclosures.
Stock Titan鈥檚 AI reads every Research Solutions SEC document the instant it hits EDGAR and delivers what professionals ask for most:
- AG真人官方-time Research Solutions insider trading Form 4 transactions alongside concise explanations of each executive move.
- Clean summaries of every Research Solutions quarterly earnings report 10-Q filing, highlighting ARR growth, churn, and platform vs. transaction revenue.
- One-click access to the Research Solutions annual report 10-K simplified with AI call-outs for goodwill from the scite and ResoluteAI deals.
- Instant alerts when an 8-K material event is filed鈥攆rom new content partnerships to CFO transitions鈥攑lus context on why it matters.
Need to understand deferred revenue tables, stock-based compensation, or proxy statement executive compensation details? Our AI-powered summaries translate accounting language into plain English, so you can focus on questions like 鈥淗ow will new AI modules lift gross margin?鈥� rather than scrolling through footnotes. In short, this page is the fastest route to understanding Research Solutions SEC documents with AI鈥攆rom insider stock moves to earnings trends鈥攚ithout getting lost in technical jargon.
Research Solutions COO Scott Ahlberg reported a Form 4 filing on June 28, 2025, disclosing a transaction that occurred on June 20, 2025. The insider surrendered 933 shares of common stock at a price of $2.69 per share to cover tax obligations related to vested restricted stock.
Following the transaction, Ahlberg maintains direct beneficial ownership of 543,549 shares of Research Solutions common stock. The share surrender was specifically approved by the Compensation Committee of the company's Board of Directors.
- Transaction Code: F (Payment of exercise price or tax liability using portion of securities received)
- Ownership Type: Direct
- Transaction Purpose: Tax liability coverage for vested restricted stock
Research Solutions CEO Roy W. Olivier reported a Form 4 filing on June 28, 2025, disclosing a transaction dated June 20, 2025. The insider, who serves as both Director and CEO & President, surrendered 2,126 shares of Common Stock at a price of $2.69 per share.
The transaction was coded as 'F', indicating shares were surrendered to cover tax obligations related to vested restricted stock. This surrender was specifically approved by the company's Compensation Committee of the Board of Directors.
Following the reported transaction, Olivier maintains direct beneficial ownership of 608,253 shares of Research Solutions common stock. The transaction demonstrates standard executive compensation tax management practices rather than discretionary trading activity.
Research Solutions CFO William Nurthen reported a Form 4 filing on June 28, 2025, disclosing a transaction that occurred on June 20, 2025. The insider surrendered 2,909 shares of Common Stock at a price of $2.69 per share to cover tax obligations related to vested restricted stock.
Following the transaction, Nurthen continues to hold 380,607 shares directly. The share surrender was specifically approved by the Compensation Committee of the company's Board of Directors as part of standard tax withholding procedures for vested equity compensation.
- Transaction Code: F (Payment of exercise price or tax liability using portion of securities received)
- Ownership Type: Direct
- Role: CFO & Secretary
Research Solutions (RSSS) director Merrill A. McPeak exercised stock options and acquired shares on June 18, 2025. Key transaction details:
- Exercised 75,000 stock options at a strike price of $1.10 per share
- Following the transaction, McPeak directly owns 409,608 shares
- The exercised options were set to expire on June 29, 2025
- The options were originally granted on June 30, 2015 with a 10-year term
This Form 4 filing represents a standard options exercise by an insider before expiration. The transaction timing appears to be driven by the approaching expiration date rather than any specific market outlook. The exercise increases McPeak's direct equity stake in the company, potentially indicating confidence in the company's long-term prospects.
FAQ
What is the current stock price of Research Solutions (RSSS)?
What is the market cap of Research Solutions (RSSS)?
